Miura, S., M. Shibazaki, S. Kasai, S. Yasuhira and A. Watanabe et al., 2014. A somatic mutation of the KEAP1 gene in malignant melanoma is involved in aberrant NRF2 activation and an increase in intrinsic drug resistance. J. Invest. Dermatol., 134: 553-556. CrossRef | PubMed | Direct Link |
Watanabe, A., S. Yasuhira, T. Inoue, S. Kasai and M. Shibazaki et al., 2013. BCL 2 and BCL xL are key determinants of resistance to antitubulin chemotherapeutics in melanoma cells. Exp. Dermatol., 22: 518-523. CrossRef | Direct Link |
